Application

RELUMIDOR

Alkermes Pharma Ireland Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88876512
Filing Date: 04/17/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88876512
MARK INFORMATION
*MARK RELUMIDOR
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT RELUMIDOR
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Alkermes Pharma Ireland Limited
INTERNAL ADDRESS CONNAUGHT HOUSE
*MAILING ADDRESS 1 Burlington Road
*CITY Dublin
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
*EMAIL ADDRESS nrich@foley.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Norm J. Rich
ATTORNEY DOCKET NUMBER 029318-2826
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Foley & Lardner LLP
INTERNAL ADDRESS Sixth Floor
STREET 3000 K Street, N.W.
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20007
PHONE 202-672-5300
FAX 202-672-5399
EMAIL ADDRESS IPDocketing@foley.com
OTHER APPOINTED ATTORNEY all other attorneys of Foley & Lardner LLP
CORRESPONDENCE INFORMATION
NAME Norm J. Rich
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE IPDocketing@foley.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) nrich@foley.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE / Richie Paul /
SIGNATORY'S NAME Richie Paul
SIGNATORY'S POSITION Director
SIGNATORY'S PHONE NUMBER +353 90 649 5000
DATE SIGNED 04/17/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88876512
Filing Date: 04/17/020

To the Commissioner for Trademarks:

MARK: RELUMIDOR (Standard Characters, see mark)
The literal element of the mark consists of RELUMIDOR. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Alkermes Pharma Ireland Limited, a corporation of Ireland, having an address of
      CONNAUGHT HOUSE
      1 Burlington Road
      Dublin
      Ireland
      nrich@foley.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Norm J. Rich. Other appointed attorneys are all other attorneys of Foley & Lardner LLP. Norm J. Rich of Foley & Lardner LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Sixth Floor
      3000 K Street, N.W.
      Washington, District of Columbia 20007
      United States
      202-672-5300(phone)
      202-672-5399(fax)
      IPDocketing@foley.com
The docket/reference number is 029318-2826.
Norm J. Rich submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Norm J. Rich
       PRIMARY EMAIL FOR CORRESPONDENCE: IPDocketing@foley.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): nrich@foley.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: / Richie Paul /   Date: 04/17/2020
Signatory's Name: Richie Paul
Signatory's Position: Director
Payment Sale Number: 88876512
Payment Accounting Date: 04/17/2020

Serial Number: 88876512
Internet Transmission Date: Fri Apr 17 14:14:25 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-202004171414257780
52-88876512-7105a76df5d59e87afa57d2f7970
d3e757d7a5196648764b6bd5b9f36a20fec2-CC-
14244395-20200417130914425427

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed